Rubicon Organics Inc. Secures $4‑Million Financing and Appoints New Chief Financial Officer
Rubicon Organics Inc. (TSXV: ROMJ, OTCQX: ROMJF) announced a $4‑million financing arrangement with a credit union on 11 November 2025. The funding is intended to support the company’s strategic growth initiatives, including expansion of its premium cannabis product line and scaling of operational capabilities.
On 12 November 2025, the company named Glen Ibbott as its Chief Financial Officer and Corporate Secretary. Ibbott brings extensive experience from the cannabis industry, having served as Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB). His appointment is expected to strengthen Rubicon’s financial leadership as the company continues to scale operations and solidify its position as a Canadian premium cannabis producer.
Rubicon Organics is a specialty pharmaceutical producer and distributor focused on growing, processing, and marketing medical marijuana and cannabis in North America. The company’s shares closed at CAD 0.51 on 10 November 2025, within a 52‑week range of CAD 0.30 to CAD 0.73. With a market capitalization of approximately CAD 33.6 million, Rubicon maintains a high price‑to‑earnings ratio of 130.77, reflecting its growth orientation and the premium nature of its product portfolio.
